Determination of α-amylase using 4- O-β- d-galactopyranosylmaltotetraose (Gal-G4) as a substrate
A new substrate, 4- O-β- d-galactopyranosylmaltotetraose (Gal-G4) is applied for the determination of α-amylase in serum and urine in a coupled assay with α-glucosidase (EC 3.2.1.20), glucokinase (EC 2.7.1.2) and glucose-6-phosphate dehydrogenase (EC 1.1.1.49) as auxiliary enzymes. Gal-G4 having a 4...
Gespeichert in:
Veröffentlicht in: | Clinica chimica acta 1998-05, Vol.273 (1), p.1-12 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A new substrate, 4-
O-β-
d-galactopyranosylmaltotetraose (Gal-G4) is applied for the determination of α-amylase in serum and urine in a coupled assay with α-glucosidase (EC 3.2.1.20), glucokinase (EC 2.7.1.2) and glucose-6-phosphate dehydrogenase (EC 1.1.1.49) as auxiliary enzymes. Gal-G4 having a 4-position of the non-reducing-end glucose residue modified by a β-galactopyranose group is resistant for degradation by α-glucosidase as auxiliary enzyme. Moreover, this substrate is hydrolyzed at just one position by α-amylase in serum and urine. More than 99% of the products generated from Gal-G4 by α-amylase are identified 4-
O-β-
d-galactopyranosylmaltose (Gal-G2), maltose, respectively. Glucose and maltose do not interfere the value of α-amylase activity at least up to 0.056 mmol/l (1 g/dl) glucose and 0.027 mmol/l (1 g/dl) maltose, respectively. We are now carrying out this work under the authority of The Enzyme committee of Japanese Society of Clinical Chemistry (JSCC) as a standard method for determination of α-amylase in clinical chemistry. |
---|---|
ISSN: | 0009-8981 1873-3492 |
DOI: | 10.1016/S0009-8981(98)00020-5 |